FHIL vs VXUS
Federated Hermes International Leaders ETF vs Vanguard Total International Stock ETF
Which is better, FHIL or VXUS?
VXUS costs less.
VXUS has a lower expense ratio.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | FHIL | VXUS |
|---|---|---|
| Expense Ratio | 0.48% | 0.05%Best |
| AUM | $3M | $158.1B |
| Dividend Yield | 0.00% | 2.59% |
| Holdings | 92 | 8,747 |
| YTD Return | -0.22% | +15.71%Best |
| 1Y Return | - | +25.07% |
| 3Y Return (annualized) | - | +20.30% |
| 5Y Return (annualized) | - | +9.21% |
| Fund Family | Federated Hermes | Vanguard (US) |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Jun 17, 2026 | Jan 26, 2011 |
Not shown on this pair: Volatility (annualized), Max Drawdown, $10,000 over the window, Top 10 Weight.
FHIL vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view is available from the range buttons; it is not the opening view here because over the whole period one of these two funds moves so much further than the other that its line would sit flat on the axis.
FHIL vs VXUS Performance
Federated Hermes International Leaders ETF (FHIL) is an ETF from Federated Hermes and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Year to date, FHIL is down 0.22% versus a gain of 15.71% for VXUS.
Past performance does not guarantee future results.
Fees and Cost Over Time
FHIL charges 0.48% per year while VXUS charges 0.05%. On a $10,000 position that is $48 vs $5 annually, a gap of $43 per year that compounds over a long holding period. On income, FHIL currently yields 0.00% against 2.59% for VXUS.
Holdings Overlap
At least 50.3% of FHIL's money is in holdings VXUS also owns.
Stated as a floor: for VXUS, our book for it covers 87.5% of that fund, so a holding it does not list is one we cannot count as shared. The real figure is this or higher.
The two portfolios partly overlap.
The two holdings books were reported 49 days apart, FHIL as of Aug 18, 2026 and VXUS as of Jun 30, 2026, so some of the difference between them is the time between the two reports rather than the funds.
37 positions in common, counted across the 84 positions we hold weights for in FHIL and 8,092 in VXUS, against full books of 92 and 8,747.
Top Shared Holdings
| Stock | Weight in FHIL | Weight in VXUS | Difference |
|---|---|---|---|
| ASML:ASAsml Holding Nv | 2.64% | 1.70% | 0.94% |
| AZN:LNAstrazeneca Plc | 2.96% | 0.62% | 2.34% |
| HSBA:LNHsbc Holdings Plc | 1.90% | 0.72% | 1.18% |
| 6758:JPSony Corp | 2.26% | 0.26% | 2.00% |
| LVMH:PALVMH | 2.17% | 0.30% | 1.87% |
| DSV:CODsv A/S | 2.33% | 0.10% | 2.23% |
| UCG:MIUnicredit Spa | 2.12% | 0.30% | 1.82% |
| 6861:JPKeyence Corp_None_0 | 2.11% | 0.21% | 1.90% |
| SOGN:PASociete Generale Sa | 2.08% | 0.13% | 1.95% |
| SGO:PACompagnie De Saint Gobain Sa | 2.07% | 0.09% | 1.98% |
50.3% of FHIL is already inside VXUS.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, FHIL or VXUS?
FHIL has an expense ratio of 0.48% while VXUS charges 0.05%. VXUS is the cheaper option, by $43 a year on a $10,000 investment.
What is the holdings overlap between FHIL and VXUS?
At least 50.3% of FHIL's money is in holdings VXUS also owns. Our book for VXUS is partial, so the real figure is this or higher. They hold 37 positions in common, counted across the 84 positions we hold weights for in FHIL and 8,092 in VXUS.
Which pays a higher dividend, FHIL or VXUS?
FHIL yields 0.00% while VXUS yields 2.59%, so VXUS currently pays the higher dividend yield.
Is VXUS better than FHIL?
VXUS has a lower expense ratio. Which one suits a particular account depends on what it is for. This is information, not a recommendation.